Cost-benefit analysis of general anesthesia using the muscle relaxant antagonist sugammadex
碩士 === 義守大學 === 管理碩博士班 === 107 === Background. Neuromuscular blocking agents such as rocuronium are widely used to maintain patient immobilization and facilitate mechanical ventilation support during general anesthesia. Therefore, the recovery of voluntary muscle power is essential during the emerge...
Main Authors: | Shu-Chuan Chen, 陳淑娟 |
---|---|
Other Authors: | Jen-Sin Lee |
Format: | Others |
Language: | zh-TW |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/xd279f |
Similar Items
-
Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex
by: Sorin J Brull, et al.
Published: (2009-04-01) -
Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment
by: D Chambers, et al.
Published: (2010-07-01) -
Benefits and risks of sugammadex
by: Jong-Yeon Park
Published: (2015-02-01) -
Rocuronium-Sugammadex in Anesthesia for Electroconvulsive Therapy
by: Nilay Tas, et al.
Published: (2016-03-01) -
The Effects of Sugammadex on Vitamin D Levels in Rabbits Under General Anesthesia
by: Tuğba Hünerel, et al.
Published: (2019-12-01)